Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Clinical Trial1
- Clinical Study1
- Controlled Clinical Trial1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Pharmakopsychiatr Neuropsychopharmakol1
Search Results
Sort by
- BookRuth Dennis, Robert M. Kirberger, Frances Barr, Robert H. Wrigley.Summary: This book is intended for all users of small animal diagnostic imaging, from radiologists through to general practitioners to veterinary students, and will be an invaluable supplement to existing references in the subject. --Book Jacket.
Contents:
Skeletal system : general
Joints
Appendicular skeleton
Head and neck
Spine
Lower respiratory tract
Cardiovascular system
Other thoracic structures : pleural cavity, mediastinum, thoracic oesophagus, thoracic wall
Other abdominal structures : abdominal wall, peritoneal and retroperitoneal cavities, parenchymal organs
Gastrointestinal tract
Urogenital tract
Soft tissues.Digital Access ScienceDirect 2010 - ArticleOppel F, Schulze G.Pharmakopsychiatr Neuropsychopharmakol. 1978 Mar;11(2):76-80.The influence of prodipin, a putative dopamine releasing compound, on the concentration of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the spinal liquor of 28 patients with Parkinson's disease was investigated. The patients were divided into three groups. In group 1 the combined antiparkinson therapy was interrupted, and 20 mg prodipin was infused. In group 2 and 3 the therapy was continued, while an additional 20 mg of prodipin was administered by infusion only to group 3. 4 Liquor-samples were obtained from each patient: 1 basic value and three additional samples 5, 8 and 24 hours after administration of 2 g probenecid. The base concentration of HVA was 15 ng/ml and this was not increased by probenecid in group 1; the concentration of 5-HIAA was 11.6 ng/ml and this was doubled by probenecid to 22.9 ng/ml. The HVA concentration increased to a maximum of 28.9 ng/ml during continued therapy (group 2); the elevated 5-HIAA remained unchanged. Prodipin does not cause an alteration in metabolite concentration in cases of interrupted therapy (group 1), but leads, in the case of continued therapy, to a 1.8-fold increase in HVA, and a 1.6-fold increase in 5-HIAA (group 3).